<code id='FB6548E3A2'></code><style id='FB6548E3A2'></style>
    • <acronym id='FB6548E3A2'></acronym>
      <center id='FB6548E3A2'><center id='FB6548E3A2'><tfoot id='FB6548E3A2'></tfoot></center><abbr id='FB6548E3A2'><dir id='FB6548E3A2'><tfoot id='FB6548E3A2'></tfoot><noframes id='FB6548E3A2'>

    • <optgroup id='FB6548E3A2'><strike id='FB6548E3A2'><sup id='FB6548E3A2'></sup></strike><code id='FB6548E3A2'></code></optgroup>
        1. <b id='FB6548E3A2'><label id='FB6548E3A2'><select id='FB6548E3A2'><dt id='FB6548E3A2'><span id='FB6548E3A2'></span></dt></select></label></b><u id='FB6548E3A2'></u>
          <i id='FB6548E3A2'><strike id='FB6548E3A2'><tt id='FB6548E3A2'><pre id='FB6548E3A2'></pre></tt></strike></i>

          
          WSS
          IQVIA signage. -- health tech coverage from STAT
          Adobe

          The health data giant IQVIA became a dominant force by gobbling up its rivals. Over decades, it feasted on upstarts with new datasets or novel technologies, growing into a juggernaut with no peer in the business of brokering Americans’ medical information.

          Now, government regulators say, IQVIA’s appetite for acquisition is getting out of control — and must be reined in.

          advertisement

          A Federal Trade Commission lawsuit seeking to block its acquisition of the digital advertising firm DeepIntent marks a crossroads for the company and the multi-billion dollar medical advertising economy it serves. The agency, which is seeking an injunction and temporary restraining order in federal court, argues that IQVIA’s data vault has become so large — and revealing — that it forms the substrate of an entire industry focused on showering doctors and patients with marketing messages.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          Leave your comment

          Please enter your name
          Please enter your comment

          comprehensive